Literature DB >> 17951353

Pancreatic adenocarcinoma: value of multidetector CT angiography in preoperative evaluation.

Giulia A Zamboni1, Jonathan B Kruskal, Charles M Vollmer, Jovanna Baptista, Mark P Callery, Vassilios D Raptopoulos.   

Abstract

PURPOSE: To retrospectively assess the sensitivity and specificity of multidetector computed tomographic (CT) angiography in the preoperative evaluation of pancreatic adenocarcinoma by using surgical findings as the reference standard.
MATERIALS AND METHODS: The institutional review board approved this HIPAA-compliant study; informed consent was waived. We reviewed CT reports, surgical notes, and pathology reports from 114 patients with pancreatic or distal cholangiocarcinoma who underwent multidetector CT angiography and surgery at our institution between March 2003 and March 2006. When CT findings and surgical reports were discordant, radiologists experienced in pancreatic imaging retrospectively reviewed images for lesion resectability; four-, eight-, 16-, and 64-row CT scanners were used in 54, 19, 25, and 16 patients, respectively. Collimation of 1.25 mm was used for four- and eight-row CT and 0.5 or 0.625 mm for 16- and 64-row CT. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for resectability were calculated for initial clinical interpretation and blinded retrospective review.
RESULTS: Eighty-eight patients had resectable lesions according to CT angiographic criteria (group A: 46 women, 42 men; mean age, 67 years; age range, 39-85 years): resection was aborted in 10 patients (11%). Twenty-six patients underwent surgery despite lesion unresectability assessed according to CT angiographic criteria (group B: 16 women, 10 men; mean age, 62 years; age range, 33-83 years); all lesions were confirmed as unresectable. The initial clinical interpretation of CT angiographic scans in all 114 patients had 100% sensitivity in the detection of resectability, 72% specificity, 89% PPV, and 100% NPV. These parameters did not appear to vary among different types of scanner. With the blinded retrospective evaluation by experienced readers, specificity increased to 94% and PPV to 98%, with no difference in sensitivity and NPV.
CONCLUSION: Multidetector CT angiography is an effective preoperative tool that reduces the number of aborted pancreatic resections; there is no evidence from this retrospective study suggesting varying results from the various generations of multidetector CT scanners used. (c) RSNA, 2007.

Entities:  

Mesh:

Year:  2007        PMID: 17951353     DOI: 10.1148/radiol.2453061795

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  27 in total

1.  Assessment of vascular invasion by bone and soft tissue tumours of the limbs: usefulness of MDCT angiography.

Authors:  Fabrice S Thévenin; Jean-Luc Drapé; David Biau; Raphaël Campagna; Delphine Richarme; Henri Guerini; Alain Chevrot; Frédérique Larousserie; Antoine Babinet; Philippe Anract; Antoine Feydy
Journal:  Eur Radiol       Date:  2009-12-17       Impact factor: 5.315

2.  Cross-modality PET/CT and contrast-enhanced CT imaging for pancreatic cancer.

Authors:  Jian Zhang; Chang-Jing Zuo; Ning-Yang Jia; Jian-Hua Wang; Sheng-Ping Hu; Zhong-Fei Yu; Yuan Zheng; An-Yu Zhang; Xiao-Yuan Feng
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

3.  Replaced common hepatic artery from the superior mesenteric artery: multidetector computed tomography (MDCT) classification focused on pancreatic penetration and the course of travel.

Authors:  Hong Il Ha; Min-Jeong Kim; Jihyun Kim; Sun-Young Park; Kwanseop Lee; Jang Yong Jeon
Journal:  Surg Radiol Anat       Date:  2016-01-12       Impact factor: 1.246

4.  PET/CT Fusion Scan Prevents Futile Laparotomy in Early Stage Pancreatic Cancer.

Authors:  Richard Kim; Gopi Prithviraj; Nishi Kothari; Greg Springett; Mokenge Malafa; Pamela Hodul; Jongphil Kim; Binglin Yue; Brian Morse; Amit Mahipal
Journal:  Clin Nucl Med       Date:  2015-11       Impact factor: 7.794

5.  Impact of the time interval between MDCT imaging and surgery on the accuracy of identifying metastatic disease in patients with pancreatic cancer.

Authors:  Siva P Raman; Sushanth Reddy; Matthew J Weiss; Lindsey L Manos; John L Cameron; Lei Zheng; Joseph M Herman; Ralph H Hruban; Elliot K Fishman; Christopher L Wolfgang
Journal:  AJR Am J Roentgenol       Date:  2015-01       Impact factor: 3.959

6.  Serum CA19-9 is a significant predictor among preoperative parameters for early recurrence after resection of pancreatic adenocarcinoma.

Authors:  Teiichi Sugiura; Katsuhiko Uesaka; Hideyuki Kanemoto; Takashi Mizuno; Keiko Sasaki; Hiroyoshi Furukawa; Kazuya Matsunaga; Atsuyuki Maeda
Journal:  J Gastrointest Surg       Date:  2012-03-13       Impact factor: 3.452

7.  State-of-the-art PET/CT of the pancreas: current role and emerging indications.

Authors:  Dushyant V Sahani; Pietro A Bonaffini; Onofrio A Catalano; Alexander R Guimaraes; Michael A Blake
Journal:  Radiographics       Date:  2012 Jul-Aug       Impact factor: 5.333

8.  Surgical resectability of pancreatic adenocarcinoma: CTA.

Authors:  Jimmie C Wong; Steven Raman
Journal:  Abdom Imaging       Date:  2009-05-26

Review 9.  Imaging diagnosis of pancreatic cancer: a state-of-the-art review.

Authors:  Eun Sun Lee; Jeong Min Lee
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

Review 10.  Advances in Diagnostic and Intraoperative Molecular Imaging of Pancreatic Cancer.

Authors:  Willemieke S Tummers; Juergen K Willmann; Bert A Bonsing; Alexander L Vahrmeijer; Sanjiv S Gambhir; Rutger-Jan Swijnenburg
Journal:  Pancreas       Date:  2018-07       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.